Dr. Feuerstadt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2200 Whitney Ave
Suite 360
Hamden, CT 06518Phone+1 203-281-4463Fax+1 203-287-2930- Is this information wrong?
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Gastroenterology, 2007 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
- Weill Cornell MedicineClass of 2004
Certifications & Licensure
- CT State Medical License 2010 - 2025
- NY State Medical License 2006 - 2025
- FL State Medical License 2014 - 2016
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- Clinical outcomes before and after prucalopride treatment: an observational study in patients with chronic idiopathic constipation in the USA.Lu, M., Terasawa, E., Terreri, B., Du, S., Ayyagari, R., Westermeyer, B., Pi, S., Boules, M., Lembo, A., Cash, B., Feuerstadt, P., Moshiree, B.> ;Clinical and Translational Gastroenterology. 2024 Feb 15
- Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides diff...Allegretti, J., Guo, A., Harvey, A., Yang, M., Garcia-Horton, V., Fillbrunn, M., Tillotson, G., Bancke, L., LaPlante, K., Garey, K., Khanna, S., Feuerstadt, P., Dubber...> ;Infectious Diseases and Therapy. 2024 Jan 1
- Erratum: Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection.LaPlante, K., Feuerstadt, P.> ;The American Journal of Gastroenterology. 2024 Jan 8
- Join now to see all
Authored Content
- C. Difficile Infection at DDW 2023May 2023
Press Mentions
- VIDEO: Low Risk for Congestive Heart Failure Exacerbation with Zinplava for C. DifficileMay 15th, 2023
- Four Analyses of Data for REBYOTA™ (Fecal Microbiota, Live – Jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile Infection, Presented at DDW 2023May 8th, 2023
- Retrospective Analysis of Data Evaluating Safety and Efficacy of REBYOTA™ (Fecal Microbiota, Live – Jslm) in a Real-World Patient Population with Comorbidities and Risk Factors Published in Open Forum Infectious DiseasesMay 3rd, 2023
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
Hospital Affiliations
- Milford HospitalMilford, Connecticut
- Yale-New Haven HospitalNew Haven, Connecticut
- Hospital of St RaphaelNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: